PR Newswire - Innovent Announces First Participant Dosed of IBI1...
SAN FRANCISCO and SUZHOU, China, March 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializ...
Read More

ภาษาไทย
English